respiratori
syncyti
viru
sever
seri
patient
hospit
pneumonia
implic
chlamydia
trachomati
virus
even
unusu
agent
pneumocysfi
ureapiasma
patient
afebril
pneumonia
howev
seen
primari
care
provid
outpati
set
larg
seri
patient
clinic
set
lack
nonetheless
import
clinic
inform
limit
studi
extrapol
extent
major
caus
afebril
pneumonia
discuss
chlamydia
bacteria
oblig
intracellular
parasit
two
speci
chlamydia
wellknown
human
pathogen
c
trachomati
agent
urethr
cervic
adult
conjunct
pneumonia
newborn
c
psitfaci
agent
psittacosi
zoonos
transmit
bird
third
speci
c
pneumonia
formerli
w
r
agent
recent
becom
well
establish
common
respiratori
pathogen
organ
cover
detail
elsewher
issu
mention
briefli
relat
lower
respiratori
tract
infect
infanc
development
cycl
chlamydia
involv
two
phase
infecti
form
elementari
bodi
noninfecti
form
metabol
activ
reticul
bodi
elementari
bodi
respons
attach
host
cell
engulf
organ
fusion
membran
occur
organ
releas
result
patholog
featur
includ
interstiti
pneumonia
diffus
intraalveolar
mononuclear
infiltr
eosinophil
focal
agent
rare
caus
afebril
pneumonia
infant
etiolog
relationship
controversi
see
text
aggreg
neutrophil
lymphocyt
plasma
cell
well
atelectasi
mucou
plug
also
may
c
trachomati
common
sexual
transmit
diseas
adolesc
therefor
expect
diseas
newborn
acquir
mother
rel
common
transmiss
organ
occur
vagin
deliveri
mother
infect
chlamydia
infect
cesarean
section
rare
occur
amniot
membran
ruptur
deliveri
portal
entri
subsequ
site
infect
eye
nasopharynx
respiratori
tract
vagina
infant
estim
incid
infant
born
chlamydi
infect
per
live
birth
rate
transmiss
infant
born
mother
infect
chlamydia
infant
approxim
develop
transmit
persist
organ
may
occur
long
profound
implic
diagnosi
sexual
abus
child
discuss
infant
chlamydi
pneumonia
typic
present
week
age
may
seen
earli
week
late
month
deliveri
present
usual
one
afebril
child
persist
staccato
cough
onset
cough
insidi
often
period
sever
day
week
nasal
discharg
may
may
present
physic
examin
reveal
mild
moder
ill
infant
tachypnea
rale
perhap
wheez
auscult
otiti
media
present
one
half
case
although
etiolog
role
chlamydia
middl
ear
contrversi
presenc
conjunct
newborn
young
infant
pneumonia
alert
clinician
possibl
chlamydi
infect
absenc
howev
rule
chlamydia
possibl
etiolog
agent
concomit
conjunct
may
present
time
sign
system
ill
typic
present
examin
peripher
blood
show
normal
mildli
elev
white
blood
cell
count
absolut
eosinophilia
elev
total
serum
immunoglobulin
g
specif
chlamydia
describ
classic
although
dubiou
diagnost
valu
radiograph
find
variabl
may
consist
hyperinfl
diffus
bilater
infiltr
infiltr
may
interstiti
reticular
nodular
fig
virus
common
caus
pneumonia
children
certainli
respons
major
case
afebril
pneumonia
exampl
pais
et
show
pneumonia
infant
younger
l
month
age
viral
caus
similar
epidemiolog
found
older
infant
type
virus
caus
pneumonia
vari
age
howev
children
older
month
age
infant
younger
month
age
like
infect
rsv
enterovirus
rhinoviru
adenoviru
parainfluenza
viru
rsv
probabl
common
caus
afebril
pneumonia
young
infant
viru
caus
upper
respiratori
tract
infect
bronchiol
pneumonia
peak
onset
age
month
epidem
season
occurr
decemb
februari
phenomenon
well
known
practition
see
children
parainfluenza
respiratori
viru
caus
croup
respiratori
tract
infect
includ
viral
pneumonia
four
serotyp
preval
vari
degre
throughout
year
influenza
viru
caus
diseas
epidem
winter
month
three
antigen
serotyp
type
b
caus
major
diseas
viru
classifi
hemaglutinin
hl
neuraminidas
nl
glycoprotein
antigen
surfac
hospit
rate
high
first
year
life
influenza
lower
respiratori
tract
diseas
adenoviru
frequent
caus
rather
sever
pneumonia
infanc
stereotyp
subgroup
type
caus
major
respiratori
pneumonia
dissemin
diseas
newborn
often
result
perinat
transmiss
rhinovirus
widespread
caus
common
cold
implic
caus
pneumonia
young
infant
well
enterovirus
also
may
frequent
caus
pneumonia
particularli
neonat
period
fact
enterovirus
rhinovirus
adenovirus
togeth
make
case
newborn
pneumonia
hospit
virus
cmv
hsv
caus
minor
neonat
infant
pneumonia
older
infant
children
coronavirus
may
caus
pneumonia
particularli
underli
pulmonari
diseas
cmv
wellknown
caus
diseas
immunocompromis
patient
infant
infect
perinat
pneumonia
found
newborn
congenit
cmv
infant
usual
manifest
list
decreas
order
frequenc
isol
congenit
cmv
infect
role
natal
postnat
acquir
pneumonia
normal
newborn
less
clear
stango
et
al
found
cmv
reportedli
immunocompet
infant
pneumonia
followup
howev
mani
infant
die
infect
rais
question
undetect
asymptomat
infect
viru
newborn
period
common
furthermor
retrospect
review
report
isol
cmv
newborn
infant
clinic
pneumonia
role
cmv
afebril
pneumonia
normal
newborn
appear
controversi
probabl
minor
transmiss
rsv
parainfluenza
result
mainli
contact
contamin
inanim
surfac
hand
respiratori
virus
transmit
smallparticl
aerosol
occur
cough
perinat
acquisit
play
role
transmiss
adenoviru
enterovirus
cmv
hsv
may
occur
transplacent
contact
infect
content
birth
canal
postnat
contact
infect
parent
initi
contact
viru
occur
eye
nose
mouth
lead
replic
epitheli
cell
loss
slough
mucosa
stasi
mucu
ensu
lower
respiratori
tract
infect
develop
local
extens
along
respiratori
tree
usual
result
one
four
pattern
diseas
acut
bronchiol
necrot
bronchiol
interstiti
pneumon
alveolar
pneumonia
interstiti
pneumonia
bronchiol
host
defens
mechan
respiratori
virus
involv
secretori
serum
antibodi
respons
cellmedi
immun
particularli
cytotox
tcell
respons
import
well
note
uncanni
abil
respiratori
virus
develop
yeartoyear
antigen
chang
evad
host
defens
influenza
viru
agent
well
known
phenomenon
virus
rsv
abl
reinfect
individu
throughout
life
span
although
usual
first
infect
produc
lower
respiratori
tract
diseas
subsequ
bout
infect
result
rel
minor
infant
viral
pneumonia
usual
present
follow
histori
rhinorrhea
cough
compar
pneumonia
onset
viral
pneumonia
usual
rapid
present
symptom
may
rel
nonspecif
poor
feed
irrit
congest
lethargi
cyanosi
even
apnea
fever
frequent
present
especi
young
infant
fact
infant
younger
month
age
present
physic
examin
find
includ
tachypnea
rale
auscult
chest
sign
respiratori
distress
retract
nasal
flare
grunt
cyanosi
wheez
may
found
bronchiol
also
present
tachypnea
cardin
sign
pneumonia
infanc
note
regard
definit
order
definit
young
children
somewhat
contrversi
use
one
adjust
maxim
sensit
specif
tachypnea
sign
pneumonia
young
children
follow
infant
younger
month
age
respiratori
rate
greater
breath
per
minut
age
month
greater
breath
per
minut
month
greater
per
minut
white
blood
cell
count
children
viral
pneumonia
may
variabl
rang
normal
elev
predomin
neutrophil
chest
radiograph
show
commonli
interstiti
infiltr
lobar
consolid
perihilar
infiltr
atelectasi
combin
find
complic
viral
pneumonia
overal
uncommon
usual
occur
infant
underli
risk
factor
congenit
heart
diseas
immunodefici
chronic
lung
condit
instanc
infant
bronchopulmonari
dysplasia
often
affect
sever
viral
infect
virus
rsv
infant
may
left
chronic
pulmonari
compromis
follow
infect
secondari
bacteri
infect
wellknown
complic
follow
influenza
parainfluenza
diseas
often
associ
aureu
pneumonia
h
influenza
apnea
usual
follow
rsv
infect
children
younger
month
infant
may
present
cyanot
spell
usual
selflimit
although
distress
caregiv
mortal
uncommon
infant
occasion
requir
shortterm
apnea
monitor
rare
sequela
viral
pneumonia
includ
bronchiol
obliteran
adult
respiratori
distress
syndrom
unilater
hyperluc
lung
syndrom
chronic
atelectasi
pulmonari
fibrsi
asthma
follow
viral
respiratori
tract
infect
well
whether
consequ
rsv
infect
children
underli
predisposit
asthma
remain
area
controversi
overal
mortal
infect
rel
low
given
frequenc
occurr
adenoviru
howev
particularli
virul
earli
infanc
may
dissemin
viscer
organ
result
death
pneumocysti
carinii
pathogen
previous
defin
protozoan
believ
relat
fungi
base
dna
homolog
although
typic
found
caus
diseas
immunocompromis
individu
organ
associ
afebril
pneumonia
normal
infant
stango
et
studi
infant
hospit
pneumonia
children
evid
pneumocysti
infect
base
detect
circul
antigen
develop
antibodi
respons
found
appropri
control
patient
patient
age
week
present
afebril
tachypnea
wheez
sever
present
apnea
radiograph
find
includ
diffus
alveolar
fill
defect
air
trap
small
discret
peripher
nodul
segment
atelectasi
suggest
trimethoprimsulfamethoxazol
result
improv
although
uncontrol
observ
infant
seri
gener
quit
ill
preselect
inpati
hospit
median
day
immunolog
abnorm
found
infant
although
one
child
die
infect
later
conceiv
technic
method
use
evalu
immunolog
function
may
miss
signific
abnorm
although
state
art
time
studi
question
aris
p
carinii
caus
less
sever
form
afebril
pneumonia
immunolog
normal
children
answer
question
remain
unknown
seroepidemiolog
studi
report
normal
infant
develop
antibodi
p
carinii
year
age
approxim
year
like
children
develop
asymptomat
infect
mild
infect
went
undiagnos
caus
pneumocysti
emerg
hiv
infect
unit
state
renew
interest
p
carinii
caus
pneumonia
infant
p
carinii
pneumonia
common
opportunist
infect
children
perinat
acquir
hiv
infect
peak
time
present
infant
occur
month
infant
typic
present
tachypnea
respiratori
distress
hypoxia
interstiti
infiltr
chest
radiograph
mortal
high
even
antimicrobi
therapi
agent
trimethoprimsulfamethoxazol
use
prevent
diseas
hivinfect
infant
mycoplasma
genu
bacteria
smallest
freeliv
microorgan
natur
ureaplasma
urealyticum
homini
frequent
inhabit
genit
tract
may
play
role
afebril
pneumonia
infanc
role
etiolog
agent
diseas
entiti
remain
controversi
clear
two
speci
caus
seriou
diseas
neonat
ureaplasma
associ
prematur
develop
chronic
lung
diseas
infant
low
birth
weight
homini
u
urealyticum
link
cn
infect
well
p
pl
n
mening
intracrani
hemorrhag
hydrocephalu
associ
presenc
organ
preterm
neonat
mani
infant
concomit
pneumon
establish
evid
infecti
role
normal
term
newborn
difficult
stango
et
studi
infant
week
age
pneumon
infant
present
tachypnea
cough
retract
rale
infiltr
chest
radiograph
afebril
author
found
patient
pneumonia
u
urealyticum
cultur
nasopharynx
compar
control
none
posit
homini
sever
difficulti
conclud
data
ureaplasma
etiolog
agent
pneumonia
first
presenc
microorgan
nasopharynx
correl
necessarili
lower
respiratori
tract
infect
second
six
eight
patient
ureaplasma
isol
signific
pathogen
cmv
c
trachomati
b
pertussi
found
concomitantli
prospect
studi
syrogionnopoulo
et
shed
doubt
hypothesi
studi
involv
infant
colon
ureaplasma
shortli
birth
author
found
lower
respiratori
tract
infect
develop
colon
infant
uncolon
infant
conclud
increas
risk
lower
respiratori
tract
infect
infant
colon
u
urealyticum
although
power
studi
detect
risk
address
role
ureaplasma
afebril
pneumonia
remain
dubiou
children
usual
ill
enough
warrant
definit
tissu
diagnosi
although
isol
lung
tissu
amniot
fluid
remolecular
techniqu
polymeras
chain
reaction
may
help
shed
addit
light
problem
despit
widespread
immun
b
pertussi
continu
frequent
caus
respiratori
ill
includ
pneumonia
young
children
afebril
infant
present
histori
rhinorrhea
cough
known
catarrh
stage
follow
paroxysm
stage
bout
sever
cough
classic
inspiratori
whoop
observ
vomit
attack
common
infant
younger
month
may
present
apnea
age
group
characterist
whoop
frequent
absent
convalesc
stage
ill
follow
cough
persist
long
sever
month
recurr
cough
subsequ
respiratori
infect
infrequ
complic
pertussi
includ
seizur
hypox
encephalopathi
apnea
physic
examin
usual
rel
normal
although
occasion
rale
rhonchi
may
heard
white
blood
cell
count
show
characterist
lymphocytosi
although
young
infant
respons
may
lack
white
blood
cell
count
may
normal
chest
radiograph
show
perihilar
infiltr
shaggi
heart
lobar
infiltr
atelectasi
pertussi
consid
even
immun
infant
recent
report
suggest
efficaci
wholecel
pertussi
vaccin
much
lower
epect
c
pneurnonia
rel
newli
recogn
respiratori
tract
pathogen
older
children
adolesc
common
caus
afebril
pneumonia
popul
two
larg
populationbas
studi
one
one
fail
detect
serolog
evid
previou
infect
c
pneurnonia
children
younger
year
furthermor
yeung
et
specif
look
serolog
evid
agent
infant
lower
respiratori
tract
infect
found
none
infect
report
clear
c
pneurnonia
rare
caus
pneumonia
infanc
pneurnonia
also
frequent
caus
afebril
pneumonia
children
age
older
like
c
pneurnonia
pneurnonia
much
less
frequent
caus
pneumonia
infanc
although
seroepidemiolog
studi
shown
antibodi
mycoplasrna
children
younger
year
age
prospect
studi
infant
daycar
center
indic
infant
cultur
posit
mycoplasrna
infant
present
pneumonia
first
sever
month
life
therefor
unlik
infect
may
part
passiv
transfer
protect
matern
antibodi
diagnosi
afebril
pneumonia
clinic
one
base
criteria
delin
earlier
chest
radiograph
provid
addit
evid
pulmonari
diseas
correct
clinic
set
find
chest
radiograph
variabl
may
includ
hyperinfl
perihilar
infiltr
patchi
consolid
atelectasi
interstiti
infiltr
alveolar
defect
even
nodular
appear
see
fig
chest
radiograph
shown
poor
sensit
specif
differenti
typic
bacteri
pneumonia
nonbacteri
pneumonia
even
combin
clinic
method
determin
caus
afebril
pneumonia
commonli
avail
list
tabl
c
trackornati
isol
organ
cultur
eye
nasopharynx
rectum
consid
gold
standard
rapid
techniqu
enzym
immunoassay
direct
fluoresc
antibodi
approv
conjunct
sensit
molecular
techniqu
dna
probe
polymeras
chain
reaction
approv
use
children
may
valu
pneumonia
suspect
clinic
swab
nasopharynx
obtain
chlamydia
direct
fluoresc
antibodi
chlamydia
cultur
direct
fluoresc
antibodi
result
usual
avail
day
cultur
within
day
conjunct
present
swab
conjunctiva
obtain
sent
direct
fluoresc
antibodi
cultur
swab
chlamydia
cultur
must
place
transport
media
deliv
promptli
laboratori
chlamydia
fastidi
kill
easili
diagnosi
viral
pneumonia
made
use
tissu
cultur
method
rapid
antigen
techniqu
rsv
parainfluenza
influenza
take
day
adenoviru
requir
day
isol
cultur
rapid
antigen
techniqu
provid
answer
matter
hour
avail
rsv
influenza
parainfluenza
adenoviru
sensit
rang
rsv
low
adenoviru
avail
test
variabl
institut
institut
rhinoviru
coronaviru
difficult
isol
cultur
serolog
test
readili
avail
enterovirus
may
cultur
identifi
serolog
respons
pneumocysti
pneumonia
difficult
diagnos
without
biopsi
bronchioaveolar
lavag
usual
reserv
infant
degre
ill
clinic
cours
would
warrant
invas
procedur
serolog
diagnosi
antigen
detect
p
carinii
experiment
wide
avail
komini
ureaplasma
identifi
cultur
nasopharyng
materi
posit
cultur
may
incident
prove
etiolog
role
pneumonia
pneumonia
associ
posit
cold
agglutinin
respons
although
nonspecif
pneumonia
c
pneumonia
confirm
igm
igg
specif
serolog
agent
may
isol
tissu
cultur
respiratori
tract
specimen
nasopharyng
swab
given
expens
delay
receiv
result
need
institut
treatment
earli
usual
mild
degre
ill
major
infant
afebril
pneumonia
requir
aforement
diagnost
techniqu
identifi
specif
etiolog
agent
situat
particular
would
warrant
evalu
first
infant
clinic
cours
compat
c
trachomati
pneumonia
name
infant
week
age
afebril
staccato
cough
without
conjunct
diagnosi
chlamydia
infant
necessit
investig
treatment
mother
sex
partner
accord
center
diseas
control
prevent
normal
infant
rather
sever
degre
ill
infant
underli
condit
immunodefici
warrant
thorough
search
etiolog
agent
investig
infant
may
warrant
commun
outbreak
influenza
epidem
knowledg
caus
agent
instanc
may
suggest
specif
use
therapi
obviat
use
ineffect
therapeut
agent
time
clinician
face
infant
afebril
pneumonia
etiolog
agent
known
one
must
decid
whether
treat
child
empir
sever
practic
consider
must
consid
make
decis
establish
etiolog
diagnosi
difficult
may
take
day
week
point
patient
may
recov
ill
would
benefit
littl
diagnosi
establish
caus
expens
requir
multipl
diagnost
test
cost
markedli
exceed
empir
cours
antibiot
larg
percentag
case
viral
caus
patient
benefit
antibiot
distinguish
bacteri
viral
diseas
clinic
ground
often
difficult
treatment
effect
institut
earli
diseas
especi
agent
chlamydia
mycoplasma
reason
approach
face
infant
whose
clinic
pictur
suggest
afebril
pneumonia
radiograph
find
compat
diagnosi
institut
therapi
erythromycin
mgkgd
four
divid
dose
day
cours
day
recommend
c
trachomati
b
pertussi
diagnos
highli
suspect
spectrum
erythromycin
includ
chlamydia
mycoplasma
pneumonia
staphylococcu
ureaplasma
b
pertussi
otiti
media
also
present
combin
drug
erythromycin
sulfasoxazol
provid
addit
action
otiti
media
pathogen
h
infuenza
cattarhali
newer
macrolid
clarithromycin
azithromycin
invitro
spectrum
span
agent
avail
suspens
form
approv
treatment
otiti
media
approv
treatment
pneumonia
infanc
effect
offer
attract
altern
patient
gastrointestin
intoler
erythromycin
specif
antivir
therapi
use
certain
circumst
ribavirin
treatment
rsv
lower
respiratori
tract
diseas
may
consid
infant
underli
condit
congenit
heart
diseas
bronchopulmonari
dysplasia
chronic
lung
diseas
immunocompromis
amantidin
rimantidin
antivir
agent
activ
influenza
viru
approv
use
infant
prevent
afebril
pneumonia
involv
prevent
infect
multitud
agent
discuss
prevent
pneumonia
c
trachomati
involv
test
treat
mother
partner
pregnanc
vaccin
influenza
recommend
children
underli
heart
lung
diseas
chronic
diseas
asthma
diabet
sicklecel
anemia
recommend
infant
younger
month
age
immun
b
pertussi
routin
part
well
child
care
children
start
month
age
great
stride
prevent
ill
made
vaccin
prevent
infect
respiratori
virus
avail
use
age
group
afebril
pneumonia
earli
infanc
common
problem
face
practition
see
children
infant
present
usual
without
fever
infiltr
chest
radiographi
varieti
pattern
respiratori
virus
common
agent
clinic
syndrom
follow
frequenc
c
trachomati
b
pertussi
unlik
older
children
newborn
infant
younger
month
age
rare
affect
c
pneurnonia
pneurnonia
agent
pneumocysti
ureaplasma
histor
implic
play
role
diseas
normal
infant
conclus
evid
confirm
role
lack
howev
diagnosi
caus
afebril
pneumonia
use
chlamydia
anoth
bacteri
agent
suspect
reli
varieti
rapid
antigen
cultur
techniqu
therapi
erythromycin
benefit
infant
infect
caus
common
nonvir
agent
caus
pneumonia
age
group
immun
infant
detect
treatment
chlamydia
pregnant
woman
import
prevent
diseas
infanc
